A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis
-
Published:2020-03-24
Issue:1
Volume:11
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
D’Alessandro-Gabazza Corina N., Kobayashi Tetsu, Yasuma Taro, Toda Masaaki, Kim Heejin, Fujimoto Hajime, Hataji Osamu, Takeshita Atsuro, Nishihama Kota, Okano Tomohito, Okano Yuko, Nishii Yoichi, Tomaru Atsushi, Fujiwara Kentaro, D’Alessandro Valeria Fridman, Abdel-Hamid Ahmed M., Ren Yudong, Pereira Gabriel V.ORCID, Wright Christy L., Hernandez Alvaro, Fields Christopher J.ORCID, Yau Peter M., Wang Shujie, Mizoguchi Akira, Fukumura Masayuki, Ohtsuka Junpei, Nosaka TetsuyaORCID, Kataoka Kensuke, Kondoh Yasuhiro, Wu Jing, Kawagishi HirokazuORCID, Yano Yutaka, Mackie Roderick I., Cann Isaac, Gabazza Esteban C.
Abstract
AbstractIdiopathic pulmonary fibrosis (IPF) is a chronic and fatal disease of unknown etiology; however, apoptosis of lung alveolar epithelial cells plays a role in disease progression. This intractable disease is associated with increased abundance of Staphylococcus and Streptococcus in the lungs, yet their roles in disease pathogenesis remain elusive. Here, we report that Staphylococcus nepalensis releases corisin, a peptide conserved in diverse staphylococci, to induce apoptosis of lung epithelial cells. The disease in mice exhibits acute exacerbation after intrapulmonary instillation of corisin or after lung infection with corisin-harboring S. nepalensis compared to untreated mice or mice infected with bacteria lacking corisin. Correspondingly, the lung corisin levels are significantly increased in human IPF patients with acute exacerbation compared to patients without disease exacerbation. Our results suggest that bacteria shedding corisin are involved in acute exacerbation of IPF, yielding insights to the molecular basis for the elevation of staphylococci in pulmonary fibrosis.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference86 articles.
1. Ley, B., Collard, H. R. & King, T. E. Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183, 431–440 (2011). 2. Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941–1952 (2017). 3. du Bois, R. M. An earlier and more confident diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. Rev. 21, 141–146 (2012). 4. King, T. E. Jr., Pardo, A. & Selman, M. Idiopathic pulmonary fibrosis. Lancet 378, 1949–1961 (2011). 5. King, T. E. Jr., Noble, P. W. & Bradford, W. Z. Treatments for idiopathic pulmonary fibrosis. N. Engl. J. Med. 371, 783–784 (2014).
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|